Back
Amicus Therapeutics Stock Predictions
![](/images/offers/ims/large/offer4.jpg)
FREE Report: Could these High Yield Stocks wreck your retirement?
Get Your Copy of "20 High-Yield Dividend Stocks that Could Ruin Your Retirement" Here.
Sell
47
FOLD
Amicus Therapeutics
Last Price:
9.82
Seasonality Move:
9.11%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer9.jpg)
The #1 free indicator I've used for 30 years
The indicator is free... and the 23-page book I wrote for you is also free.Amicus Therapeutics Stock Forecast
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23% based on the past 17 years of stock performance.
- Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
-
Is Amicus Therapeutics Stock Undervalued?
The current Amicus Therapeutics [FOLD] share price is $9.81. The Score for FOLD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 23% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
47
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
- Amicus Therapeutics has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
14.57
52-Week Low:
9.02
Prediction Charts
Market Cap:
2.91B
Price in USD:
9.81
Volume:
511.08K
Beta:
1.02
Technical Analysis
SMA50:
9.97
SMA100:
11.06
SMA200:
11.48
52-Wk Change:
-20.18%
Stock Predictions
-
Is Amicus Therapeutics stock public?
Yes, Amicus Therapeutics is a publicly traded company. -
What is the Amicus Therapeutics stock quote today?
The Amicus Therapeutics stock price is 9.81 USD today. -
How to buy Amicus Therapeutics stock online?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-13 | 10.59 | 10.65 | 10.87 | 10.59 |
Jun-14 | 10.53 | 10.14 | 10.57 | 10.13 |
Jun-17 | 10.00 | 10.04 | 10.06 | 9.83 |
Jun-18 | 10.07 | 9.77 | 10.07 | 9.76 |
Jun-20 | 9.67 | 9.80 | 9.97 | 9.56 |
Jun-21 | 9.84 | 10.10 | 10.14 | 9.81 |
Jun-24 | 10.16 | 10.00 | 10.38 | 9.98 |
Jun-25 | 9.93 | 9.85 | 10.02 | 9.81 |
Jun-26 | 9.82 | 9.71 | 9.88 | 9.59 |
Jun-27 | 9.70 | 9.91 | 9.97 | 9.64 |
Jun-28 | 9.91 | 9.92 | 10.05 | 9.75 |
Jul-1 | 9.85 | 9.80 | 10.03 | 9.77 |
Jul-2 | 9.76 | 9.85 | 9.87 | 9.68 |
Jul-3 | 9.95 | 9.81 | 9.99 | 9.81 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.02 per share, an increase this year of $0.55 per share, and an increase next year of $0.32 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.